It is possible, however, that vandetanib inhibition of EGFR or VEGFR in vivo may alleviate some of the pathology of dengue hemorrhagic fever and dengue shock syndrome; VEGFR signaling directly induces vasodilation (49). Here, EGFR is linked to Dengue hemorrhagic fever.